2007
DOI: 10.1016/j.bbrc.2007.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Pirfenidone inhibits TGF-β expression in malignant glioma cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
49
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 60 publications
(51 citation statements)
references
References 26 publications
2
49
0
Order By: Relevance
“…The differentiation medium was composed of Dulbecco's modified Eagle's medium (DMEM) and 3% (v/v) horse serum (Gibco). Pirfenidone (Selleck, USA; 20 μg/ml; Burghardt et al., 2007) was used to stimulate the satellite cells continuously for 24 hr.…”
Section: Methodsmentioning
confidence: 99%
“…The differentiation medium was composed of Dulbecco's modified Eagle's medium (DMEM) and 3% (v/v) horse serum (Gibco). Pirfenidone (Selleck, USA; 20 μg/ml; Burghardt et al., 2007) was used to stimulate the satellite cells continuously for 24 hr.…”
Section: Methodsmentioning
confidence: 99%
“…Lysates for immunoblots and cell culture supernatants were prepared as described previously (27,28). Briefly, supernatants were generated for 72 hours after plating 3 Â 10 6 cells in serum-free medium.…”
Section: Methodsmentioning
confidence: 99%
“…Likewise, the TGF-b inhibitor perfenidone decreased MMP-11, but not MMP-2, in malignant glioma cells (61). However, earlier studies with human myometrial cells demonstrated an inhibition of MMP-1 and MMP-3 with TGF-b1 treatment (26).…”
Section: Figurementioning
confidence: 96%